Latest Articles

Publication Date
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer - OncLive

Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer OncLive

Published: April 18, 2025, 3:54 p.m.
Chronic Pelvic Pain Treatment Market Size will Projected to Hit - openPR.com

Chronic Pelvic Pain Treatment Market Size will Projected to Hit openPR.com

Published: April 18, 2025, 12:17 p.m.
Chance test spotted symptom-less pre-cancer in 25-year-old's colon - MSN

Chance test spotted symptom-less pre-cancer in 25-year-old's colon MSN

Published: April 18, 2025, 9:09 a.m.
‘Incredibly disappointing’: Period pain education program scrapped - The Mercury

‘Incredibly disappointing’: Period pain education program scrapped The Mercury

Published: April 18, 2025, 7:05 a.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Mediterranean diet strengthens bones: proven by science - Socportal.info

Mediterranean diet strengthens bones: proven by science Socportal.info

Published: April 18, 2025, 4:14 a.m.
Bindi Irwin's Health 'Took a Turn for the Worst' Prior to Endometriosis Surgery: 'She Feels Lucky' - okmagazine.com

Bindi Irwin's Health 'Took a Turn for the Worst' Prior to Endometriosis Surgery: 'She Feels Lucky' okmagazine.com

Published: April 18, 2025, 12:38 a.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Impact of Positive Peritoneal Cytology on Prognosis in Stage IA Endometrial Cancer: A Retrospective Cohort Study in the Era of Minimally Invasive Surgery - Cureus

Impact of Positive Peritoneal Cytology on Prognosis in Stage IA Endometrial Cancer: A Retrospective Cohort Study in the Era of Minimally Invasive Surgery Cureus

Published: April 17, 2025, 11:08 p.m.
‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling - GB News

‘It’s a disaster’: Trans woman who claimed her breastmilk can ‘benefit’ babies feels ‘sexless’ after Supreme Court ruling GB News

Published: April 17, 2025, 11:02 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!